Hemo AI

HEMO AI is developing a next-generation IV monitoring platform designed to improve patient safety and clinical decision-making. The company’s first product is a disposable Smart Stopcock for IV/PICC lines, enabling automated and frequent rinsing to reduce inflammation risk, improve line patency, and support safer infusion workflows. Building on this entry product, HEMO AI is developing modular sensor cartridges that allow frequent bedside monitoring of critical blood biomarkers such as hemoglobin, lactate, glucose, and additional analytes. By turning intermittent lab snapshots into continuous trends, HEMO AI aims to support earlier detection of hemorrhage, sepsis, and clinical deterioration across multiple care settings—including hospital wards, surgery, emergency care, and home hospitalization. The platform integrates biomarker monitoring with data analytics and decision-support algorithms to help clinicians identify risk earlier, optimize treatment timing, and improve outcomes. HEMO AI is advancing through preclinical and clinical stages toward regulatory approval and commercialization.